Privacy Policy PUBBLICAZIONI – Fondazione Arianna

L’attività scientifica promossa da Fondazione Arianna ha portato alla pubblicazione dei lavori su importanti riviste internazionali.
Inoltre, numerosi contributi sui dati analizzati sono stati selezionati come poster o come comunicazioni orali ai più importanti congressi nazionali e internazionali sull’anticoagulazione.

CONSULTA E SCARICA I NOSTRI ARTICOLI

START-Register. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation.
Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G.
PLosOne 2015

Vitamin K Antagonist Therapy: Changes in the Treated Populations and in Management Results in Italian Anticoagulation Clinics Compared with those recorded 20 years ago.
Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; on behalf of the centres participating in the FCSA-START-Register (The ISCOAT 2016 study)
Intern and Emerg Med, 2017

 

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.
Patti G, et al. Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R.
PLoS One. 2017

ARTICOLI PUBBLICATI

  • Rostagno C, Rubbieri G, Zeppa M, Cartei A, Ceccofiglio A, Mannarino GM, Palareti G, Grandone E. Management and 1-Year Outcome in Elderly Patients with Hip Fracture Surgery Receiving Anticoagulation (Warfarin or DOAc) or P2Y12 Antiplatelet Agents. J Clin Med. 2023
  • Menichelli D, Poli D, Antonucci E, Palareti G, Pignatelli P, Pastori D. Renin-angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry. Eur J Intern Med. 2023
  • Pengo V  Sarti L, Antonucci E, Di Agostino S, Bison E, Denas G, Poli D, Meroni PL Gerli R, Radice A, Palareti G. Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries. BTVB 2023
  • Menichelli D, Antonucci E, Pignatelli P, Violi F, Palareti G, Pastori D; START2 Register Investigators. Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry. Nutr Metab Cardiovasc Dis. 2023
  • Guarascio M, Bertù L, Donadini MP, Antonucci E, Palareti G, Ageno W. DOACs use in extreme body-weighted patients: results from the prospective START-register. Intern Emerg Med. 2023
  • Poli D, Ageno W, Antonucci E, Bradamante S Bucherini E, Chiarugi P, Chistolini A, Cosmi B , Falanga A, Insana A, Lione D, Lombardi MR, Malcangi G, Marcucci R,   Martini G, Masciocco L, Paparo C, Pastori D, Pedrini S, Pengo V, Pignatelli P, Toma A testa S, Palareti G. Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START). BTVB 2023
  • Grandone E, Antonucci E, Colaizzo D, De Laurenzo A, Cosmi B, Cini M, Legnani C, Testa S, Margaglione M, Palareti G. Venous thromboembolism in women of childbearing age: insights from the START registry. Thromb Haemost. 2023
  • Ageno W, Antonucci E, Poli D, Bucherini E, Chistolini A, Fregoni V, Lerede T, Pancani R, Pedrini S, Pieralli F, Pignatelli P, Pizzini AM, Podda GM, Potere N, Sarti L, Testa S, Visonà A, Palareti G; START 2 Registry VTE study group.  Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes. Res Pract Thromb Haemost. 2023
  • Palareti G, Legnani C, Poli D, Ageno W, Pengo V, Testa S, Tosetto A, Prandoni P; NEUROFARBA, University of Florence, Italy. COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study. Haematologica 2023
  • Prandoni P, Lensing AWA, Prins MH, Ciammaichella M, Pirillo S, Pace F, Zalunardo B, Bottino F, Ageno W, Muiesan ML, Forlin M, Depietri L, Bova C, Costantini N, Caviglioli C, Migliaccio L, Noventa F, Levi M, Davidson BL, Palareti G; Pulmonary Embolism Dyspnea Italian Study (PEDIS) Investigators. Prevalence of pulmonary embolism among patients with recent onset of dyspnea on exertion. A cross-sectional study. J Thromb Haemost. 2023
  • Poli D, Antonucci E, Ageno W, Prandoni P, Barillari G, Bitti G, Imbalzano E, Bucherini E, Chistolini A, Fregoni V, Galliazzo S, Gandolfo A, Grifoni E, Mastroianni F, Panarello S, Pesavento R, Pedrini S, Sala G, Pignatelli P, Preti P, Simonetti F, Sivera P, Visonà A, Villalta S, Marcucci R, Palareti G. Thromboembolic Complications in COVID-19 Patients Hospitalized in Italian Ordinary Wards: Data from the Multicenter Observational START-COVID Register. TH Open. 2022
  • Fumagalli RM, Aimasso U, Valeriani E, Mumoli N, Szlaszynska M, Antonucci E, Palareti G, Mastroiacovo D, Di Nisio M, Barco S. Quality of warfarin anticoagulation in adults with short bowel syndrome on home parenteral nutrition. Vasa. 2022
  • Palareti G, Poli D, Ageno W, Legnani C, Antonucci E, Bucherini E, Testa S, Paoletti O, Chistolini A, Serrao A, Martinelli I, Bucciarelli P, Falanga A, Tosetto A, Sarti L, Mastroiacovo D, Cosmi B, Visonà A, Santoro RC, Zanatta N, Grandone E, Bertù L, Pengo V, Caiano L, Prandoni P. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study. Blood Adv 2022
  • Legnani C, Cini M, Testa S, Tosetto A, Dellanoce C,  Bellesso S, Carli G, Nichele I, Lissandrini L, Zorzi S, Antonucci E, Palareti G. Evaluation of Coaguchek®Pro II coagulation testing device performance to assess direct oral anticoagulant action. The DOAC-CHECK study. BTVB 2022
  • Pastori D, Antonucci E, Milanese A, Menichelli D, Palareti G, Farcomeni A, Pignatelli P. The Start Register Investigators Clinical Phenotypes of Atrial Fibrillation and Mortality Risk-A Cluster Analysis from the Nationwide Italian START Registry. J Pers Med. 2022
  • Poli D, Antonucci E,   Palareti G , Facchinetti R, Falco P, Serricchio G, Lerede T, Masciocco L, Gresele P, Sophie T. Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study. BTVB 2022
  • Palareti G, Bignamini AA, Urbanek T, Cini M, Li YJ, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Influence of clinical presentation, site, and extent of venous thrombosis on decision about duration of anticoagulation: Data from the international, prospective, observational WHITE study. Thromb Res. 2022
  • Menichelli D, Poli D, Antonucci E, Biccirè FG, Palareti G, Pignatelli P, Pastori D.  Bleeding and mortality risk in patients implanted with mechanical prosthetic heart valves with and without thrombocytopenia. Insights from the nationwide PLECTRUM registry Platelets. 2022
  • Palareti G, Bignamini A, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V; WHITE study group. Unprovoked or provoked venous thromboembolism: not the prevalent criterion to decide on anticoagulation extension in clinical practice of various countries-the prospective, international, observational WHITE study. Intern Emerg Med. 2022
  • Poli D, Antonucci E, Ageno W, Prandoni P, Palareti G, Marcucci R; START-COVID Investigators. Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register. Intern Emerg Med. 2022
  • Cesaro A, Gragnano F, Calabrò P, Moscarella E, Santelli F, Fimiani F, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Bossone E, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators. Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry. Intern J Cardiol 2021
  • Legnani C, Palareti G, Antonucci E, Poli D, Cosmi B, Falanga A, Mastroiacovo D, Testa S; START 2-Register Investigators (Appendix 1). Thrombophilia testing in the real-world clinical setting of thrombosis centres taking part in the Italian Start 2-Register. Blood Transfus. 2021
  • Palareti G, Bignamini AA, Cini M, Li YJ, Urbanek T, Madaric J, Bouslama K, Sokurenko GY, Andreozzi GM, Matuška J, Mansilha A, Barinov V. Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data from the International, Observational WHITE Study. Clin Appl Thromb Hemost. 2021
  • Poli D, Migliaccio L, Antonucci E, Biancone L, Bozzolin A, Corradetti V, Finale C, Furian L, La Manna G, Larti A, Ranghino A, Rossetti MM, Taruscia D, Palareti G, Zanazzi M. Venous thromboembolism in renal transplant recipients: Results of Venous thromboEmbolism in renal Transplant Recipients- Italian Study – VETRIS. Thromb Res. 2021
  • Palareti G, Legnani C, Antonucci E, Cosmi B, Falanga A, Poli D, Mastroiacovo D, Pengo V, Ageno W, Testa S. Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-Register. Ther Adv Drug Saf. 2021
  • Palareti G., Legnani C., Antonucci E., Testa S., Mastroiacovo D., Cosmi B, Poli D., Bucherini E. Pomero F., Fontanella A, Mumoli N,Imberti D, Ageno W., Falanga A, Dentali F. Isolated Distal Deep Vein Thromboses: A Questionable Trend Towards Long-Lasting Anticoagulant Therapy. Results From A Prospective, Observational Italian Register TH open 2021

     

  • Menichelli D, Poli D, Antonucci E, Pignatelli P, Palareti G, Testa S, Pastori D and the Italian Federation of Anticoagulation Clinics (FCSA) Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves: insights from the nationwide PLECTRUM study. Molecules 2021

     

  • Pastori D, Poli D, Antonucci E, Menichelli D, Palareti G, Violi F, Pignatelli P, Sex-based difference in anticoagulated patients with mechanical prosthetic heart valves and long-term mortality risk . Int J Clin Pract. 2021

     

  • Poli D, Antonucci E,  Pengo V, Bucherini E,  Ldigiani C,  Barcellona D,  Palareti G, Testa S on the behalf of the Italian Federation of Anticoagulation Clinics (FCSA) Association of antiplatelet and anticoagulant treatment in patients with Mechanical Prosthetic Heart Valves. Data from the observational multicentre PLECTRUM Study. Cardiol Cardiovasc Med 2021

     

  • Cavallari I, Maddaloni E, Gragnano F, Patti G, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R; START-ANTIPLATELET collaborators.   Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome. Inter Emerg Med 2021

     

  • Gresele P, Guglielmini G, Del Pinto M, Calabrò P, Pignatelli P, Patti G, Pengo V, Antonucci E, Cirillo P, Fierro T, Palareti G, Marcucci R; START Antiplatelet Registry Group. Peripheral arterial disease has a strong impact on cardiovascular outcome in patients with acute coronary syndromes: from the START Antiplatelet registry. Int Journ Cardiol 2020
  • Antonucci E, Migliaccio L, Abbattista M, Caronna A, De Marchi S, Di Giorgio A, Di Giulio R, Lerede T, Garzia MG, Martinelli I, Mastroiacovo D, Marzolo M, Montevecchi E, Pastori D, Pignatelli P, Poli D, Ria L, Santoliquido A, Testa S, Palareti G; START POST VTE Investigators. Treatment decision-making of secondary prevention after venous thromboembolism: data from the real life START2- Post VTE Registry. Clin App Th Haem 2020
  • Margaglione M, Antonucci E, D’Andrea G, Migliaccio L, Ageno W, Bucherini E, Cosmi B, Falanga A, Martini G, Mastroiacovo D, Paparo C, Poli D, Testa S, Palareti G. Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study. Blood Transfusion 2020
  • Poli D, Antonucci E, Vignini E, Martinese L, Testa S, Simioni P, Pengo V, Pignatelli P, Falanga A, Masciocco L, Barcellona D, Ciampa A, Chiarugi P, Paparo C, Ageno W, Palareti G; START2 Registry investigators.Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs. Eur J Int Med 2020
  • Gragnano F, Moscarella E, Calabrò P, Cesaro A, Pafundi PC, Ielasi A, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Pelliccia F, Gaudio C, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET Collaborators. Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry.  Intern Emerg Med. 2020
  • Cini M, Legnani C, Padrini R, Cosmi B, Dellanoce C, De Rosa G, Marcucci R, Pengo V, Poli D, Testa S, Palareti G. DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC in apixaban and rivaroxaban treated patients from the START-Register. Int J Lab Hematol 2020
  • Pastori D, Lip GYH, Poli D, Antonucci E, Rubino L, Menichelli D, Saliola M, Violi F, Palareti G, Pignatelli P; Italian Federation of Anticoagulation Clinics (FCSA). Determinants of low-quality warfarin anticoagulation in patients with mechanical prosthetic heart valves. The nationwide PLECTRUM study. British J Hematol  2020
  •    Palareti G, Legnani C, Antonucci E, Zorzi S, Bignamini AA, Lodigiani C, Tosetto A, Bertù L, Pengo V, Testa S, Ageno W, Prisco D, Prandoni P, Poli D.  Design and rationale of a randomized, placebo-controlled trial on the efficacy and safety of sulodexide for extended treatment in elderly patients after a first venous thromboembolism. Intern Emerg Med 2020
  • Cirillo P, Di Serafino L, Taglialatela V, Calabrò P, Antonucci E, Gresele P, Palareti G, Patti G, Pengo V, Pignatelli P, Marcucci R. Optimal Medical Therapy on Top of Dual-Antiplatelet Therapy: 1-Year Clinical Outcome in Patients With Acute Coronary Syndrome: The START Antiplatelet. Angiology 2020
  • Palareti G, Legnani C, Antonucci E, Cosmi B, Poli D, Testa S, Tosetto A, Ageno W, Falanga A, Ferrini PM, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators. D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study. Intern Emerg Med 2020
  • Palareti G, Antonucci E, Dentali F, Mastroiacovo D, Mumoli N, Pengo V, Poli D, Testa S, Pujatti PL, Menditto VG, Imberti D, Fontanella A. Patients with Isolated Pulmonary Embolism in Comparison to those with Deep Venous Thrombosis. Differences in Characteristics and Clinical Evolution. Eur J Int Med 2019
  • Pastori D, Antonucci E, Violi F, Palareti G, Pignatelli P; START2 Registry Investigators. Thrombocytopenia and Mortality Risk in Patients With Atrial Fibrillation: An Analysis From the START Registry J Am Heart Ass 2019
  • Calabrò P, Moscarella E, Gragnano F, Cesaro A, Pafundi PC, Patti G, Cavallari I, Antonucci E, Cirillo P, Pignatelli P, Palareti G, Sasso FC, Pengo V, Gresele P, Marcucci R; START-ANTIPLATELET collaborators, Conte M, Fimiani F, Di Serafino L, Del Pinto M, Denas G, Pastori D, Eleonora C, Fierro T.Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) Am J Cardiol 2019
  • Legnani C, Martinelli I, Palareti G, Ciavarella A, Poli D, Ageno W, Testa S, Mastroiacovo D, Ciammaichella M, Bucherini E, Mumoli N, Cosmi B. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants PlosOne 2019
  • Poli D, Antonucci E, Bertù L, Vignini E, Ruocco L, Mastroiacovo D, Paparo C, Pastori D, Testa S, Ageno W, Palareti G; coordinator of START2 Register. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAS or DOACS: results from the prospective multicenter START2-Register Study. Thromb Res 2019
  • Marcucci R, Patti G, Calabrò P, Gori AM, Grossi G, Cirillo P, Pengo V, Gresele P, Pignatelli P, Antonucci E, di Mario C, Valente S, Palareti G. Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. Plos One 2019
  • Poli D, Antonucci E, Ageno W, Bertù L, Migliaccio L, Martinese L, Pilato G, Testa S, Palareti G. Oral anticoagulation with VKAs or DOACs in very elderly patients with atrial fibrillation. Results from the prospective multicenter START2 Register study. PLosOne 2019
  • Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G; Coordinator of START2-Register. Drug Levels And Bleeding Complications In Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants. J Thromb Haemost 2019
  • Testa , C. Dellanoce, O. Paoletti, E. Cancellieri, R. Morandini, M. Tala, S. Zambelli, C. Legnani. Edoxaban plasma levels in patients with non-valvular atrial fibrillation: inter and intra-individual variability, correlation with coagulation screening test and renal function. Thromb Res 2019
  • Cini M, Legnani C, Testa S, Tripodi A, Cosmi B, Palareti G. An in-vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays. Intern Journ  Lab Hemat 2019
  • Cirillo P, Di Serafino L, Patti G, Antonucci E, Calabrò P, Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R. Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry Angiology 2019
  • Palareti G Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P. ACCP score to assess the risk of bleeding during anticoagulation: application to real-life data from the START2-REGISTRY. J Thromb Haemost, 2018
  • Poli D, Antonucci E, Pengo V, Grifoni E, Maggini N, Testa S, Lodigiani C, Insana A, Marongiu F, Barcellona D, Paparo C, Bucherini E, Pignatelli P, Palareti G, on the behalf of the Italian Federation of Anticoagulation Clinics. High risk for reoperation among patients with bioprosthetic heart valves and indication for long-term anticoagulation. Open Heart, 2018
  • Testa S, Ageno W, Antonucci E, Morandini R, Beyer-Westendorf J, Paciaroni M, Righini M, Sivera P, Verhamme P, Pengo V, Poli D, Palareti G. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Events Registry. Intern Emerg Med 2018
  • Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani L, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G coordinator of START Registry, on  the behalf of the Italian Federation of Anticoagulation Clinics. Mechanical Prosthetic Heart Valves: quality of anticoagulation and thromboembolic risk.  The observational  multicentre PLECTRUM Study. Int J Cardiol 2018
  • Testa S, Paoletti O, Cristina Legnani, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D, Morandi R, Testa R, Tripodi A, Palareti G Coordinator of START Registry. Low drug levels and thrombotic complications in high risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost 2018
  • Patti G, Ricottini E, Nenna A, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Bisignani A, Marcucci R. Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry).Am J Cardiol 2018
  • Calabrò P, Gragnano F, Di Maio M, Patti G, Antonucci E, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Pennacchi M, Granatelli A, De Servi S, De Luca L, Marcucci R; for EYESHOT Study and Start Antiplatelet Register. Epidemiology and Management of Patients With Acute Coronary Syndromes in Contemporary Real-World Practice: Evolving Trends From the EYESHOT Study to the START-ANTIPLATELET Registry. Angiology 2018
  • Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register. Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register. International Journal of Laboratory Hematology, 2018
  • Gentian D, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V. Warfarin prescription in patients with non-valvular atrial fibrillation and one non-gender related risk factor (CHA2DS2VASc 1 or 2): a treatment dilemma. Cardiovascular Therapeutics, 2017
  • Patti G, Cavallari I, Antonucci E, Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R. Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome   PLoS One 2017
  • Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; on behalf of the centres participating in the FCSA-START-Register (The ISCOAT 2016 study).Vitamin K Antagonist Therapy: Changes in the Treated Populations and in Management Results in Italian Anticoagulation Clinics Compared with those recorded 20 years ago. Intern and Emerg Med, 2017
  • Poli D, Antonucci E, Pengo V, Testa S, Palareti G. Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in patients with atrial fibrillation. Am J Cardiol 2017
  • Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, Carraro P, Salomone L, Paniccia R, Paoletti O, Poli D, Palareti G; START-Laboratory Register. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics. Thromb  Res 2016
  • Palareti G, Cosmi B, Antonucci E, Legnani C, Erba N, Ghirarduzzi A, Poli D, Testa S, Tosetto A, Pengo V, Prandoni P; DULCIS investigators. Duration of anticoagulation after isolated pulmonary embolism Eur Respir J 2016
  • Testa S, Legnani C, Tripodi A, Paoletti O, Pengo V, Abbate R, Bassi L, Carraro P, Cini M, Paniccia R, Poli D, Palareti G. Poor comparability of coagulation screening test with specific measurement in patients on direct oral anticoagulants: results from a multicenter/multiplatform study. J Thromb Haemost 2016
  • Palareti G, Antonucci E, Lip GY, Testa S, Guazzaloca G, Falanga A, Pengo V, Poli D; START-Register Participants. The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study. Thromb Haemost 2016
  • Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G; START-Register.The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation. PLosOne 2015

 

 

ARTICOLI Gruppo TRIP

  • Ageno W, Bertù L, Bucherini E, Camporese G, Dentali F, Iotti M, Lessiani G, Parisi R, Prandoni P, Sartori M, Visonà A, Bigagli E, Palareti G; RIDTS study group. Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: randomised controlled trial. BMJ. 2022 
  • Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi